For the latest COVID information Click Here.
Approval is required to advertise surveys to the ARA Membership. The procedure for Surveys of the Membership can be found here. Please advise:
Please enclose a copy of the survey, the research protocol and ethics approval with your application and send to ara@rheumatology.org.au.
Click here to complete the survey.
Researchers at The George Institute & UNSW are conducting a survey to explore key barriers and facilitators to translating research findings into practice, more specifically musculoskeletal surgery. By participating in this survey, you will help identify the key barriers and facilitators to implementing research results in surgery, with the goal of improving patient outcomes.
You have been invited because of your expertise in clinical or research fields related to musculoskeletal surgery. Your insights are invaluable in helping us understand the factors that influence the adoption of evidence in clinical practice.
The research project is looking for people who want to take part in this research and who are: i. Age > 18 years ii. And either 1. Healthcare professional currently practicing in Australia and who has cared for patients with musculoskeletal conditions in the past 12 months OR 2. Clinical researcher who has worked in the field of musculoskeletal health for at least 12 months
Participation in this research is not a requirement and your decision to or not to take part is optional and voluntary.
It will take approximately 10 minutes to complete the survey outlined in the attached Participant Information Statement, which contains a full description of the research activities, risks associated with these activities and any discomforts that you may experience during the research. If you would like to take part in this research, you can do so by selecting the following link: https://redcap.link/TGIMSKSURVEY
Survey Closes: 15 April 2025
Date Posted: 2 December 2024
Do you have patients on or ≥2 advanced immunosuppressive therapies (eg biological agents) concurrently that are not typically used in combination?
Researchers from the University of Sydney are looking to assess the important and emerging area of outcomes of these patients, via an online de-identified registry. All data is stored securely and in the strictest of confidence, and the study has been granted Human Research Ethics Committee approval.
Please follow this link for the database to fill out patient details or receive further details. The survey takes 5-10 minutes (per patient). Any clinician who fills ≥10 patients will be offered co-authorship on the academic output.
Many thanks in advance for your time
Dr John Chetwood (john.chetwood@health.nsw.gov.au) On behalf of the The Multiple Advanced Therapies Research Team
Survey Closes: 1 March 2025
Date Posted: 4 January 2024
Monash University researchers are seeking your help to identify priority questions for an Australian ‘living’ clinical practice guideline for the management of people with shoulder pain in primary care. 'Living' means that individual recommendations within the guideline will be updated as soon as new evidence emerges. Taking part involves completing an online survey (5-10 minutes). You will also be invited to complete a second round which involves ranking the aggregated results of the first round in order of priority.
This research has been approved by the Monash University Human Research Ethics Committee (ID 40633) and is funded by a project grant from Arthritis Australia. For further information, please contact Dr Romi Haas at romi.haas@monash.edu. Thank you for your consideration in participating in this study.
Date Posted: 23 December 2024
Vacuolation, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a recently described multisystem disease. The preferred method for diagnosis and specific treatment algorithm are lacking, further compounded by diagnoses in older patients with significant comorbidities making decisions quite challenging. As VEXAS involves multiple systems, the disease is often managed across many specialties: haematology, rheumatology and immunology, among others.
To better understand this disease and management around the world, a short survey is being proposed to clinicians managing VEXAS. The survey evaluates the clinician background, molecular biology testing methods and local capabilities, and physician’s preferences on therapeutic choices.
The survey will be distributed to clinicians across the globe via electronic link and results gathered anonymously. The aim is to provide a screenshot of the global VEXAS cartography in terms of diagnostic capabilities and disease awareness.
This research has been approved by the Southern Adelaide Local Health Network Research Ethics and Governance Committee (Reference 239.24).
Should you have any questions, please contact Dr Syed Ali or Professor Carmelo Gurnari for any queries.
Thank you for your consideration in participating in this study.
Survey Closes: 28 February 2025
Date Posted: 24 January 2025